Nektar Therapeutics | NKTR - Trade Creditors


Nektar Therapeutics reported $10.77M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Agios Pharmaceuticals USD 13.75M 4.61M Mar/2026
ALKERMES USD 102.36M 5.59M Mar/2026
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Amgen USD 19.52B 1.37B Mar/2026
Baxter International USD 1.09B 87M Mar/2026
BioCryst Pharmaceuticals USD 10.96M 4.87M Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Cara Therapeutics USD 3.22M 859K Dec/2025
Cipla INR 32.3B 1.95B Mar/2026
Dr.Reddys Laboratories INR 30.38B 10.42B Mar/2026
Eisai JPY 75.89B 9.6B Mar/2026
Eli Lilly USD 5.03B 350M Mar/2026
Esperion Therapeutics USD 68.41M 3.34M Mar/2026
Exelixis USD 24.15M 5.47M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Grifols EUR 987.75M 47.87M Dec/2025
Halozyme Therapeutics USD 14.1M 6.8M Mar/2026
Incyte USD 228.62M 1.41B Mar/2026
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
Ironwood Pharmaceuticals USD 3.24M 339K Mar/2026
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
MacroGenics USD 4.29M 500K Mar/2026
Merck USD 3.86B 541M Mar/2026
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
Sarepta Therapeutics USD 70.38M 210.46M Mar/2026
Takeda JPY 491.34B 23.75B Mar/2026
Teva Pharmaceutical Industries USD 2.6B 65M Mar/2026
Xencor USD 7.92M 2.91M Mar/2026